静脉溶栓治疗早期急性心肌梗死的临床效果研究  

Clinical Effect of Intravenous Thrombolysis on Early Acute Myocardial Infarction

作　　者：白帅 高智耀[2] 贺清明[1] BAI Shuai;GAO Zhi-yao;HE Qing-ming(Medical College of Yan’an University,Yan’an Shaanxi;Affiliated Hospital of Yan’an University,Yan’an Shaanxi)

机构地区：[1]延安大学医学院,陕西延安 [2]延安大学附属医院,陕西延安

出　　处：《世界最新医学信息文摘》2020年第26期172-173,共2页World Latest Medicine Information Electronic Version

摘　　要：目的探讨静脉溶栓治疗方法应用于早期急性心肌梗死中的临床效果.方法选取2018年10月至2019年10月在我院治疗早期急性心肌梗死的患者120例作为实验对象,按照实验要求随机分为实验组和对照组,两组人数各60例.对照采用常规治疗方法,实验组采用静脉溶栓治疗.记录两组数据,比较患者发病6h内治疗和6~12h内治疗的血管再通情况,比较两组患者的不良反应发生率以及治疗总有效率.结果实验组的患者发病后6h内静脉溶栓治疗的血管再通率为86.67%,实验组的患者6~12h静脉溶栓治疗的血管再通率为75.00%(P<0.05).实验组的不良反应发生率为15%低于对照组的40%(P<0.05).实验组的治疗总有效率为86.67%高于对照组的63.33%(P<0.05).结论对早期急性心肌梗死患者采用静脉溶栓治疗,能够有效的提高患者的血管再通率和治疗总有效率,降低不良反应的发生率,相对于常规治疗具有显著的临床疗效,因此,值得在临床上推广应用.Objective To investigate the clinical effect of intravenous thrombolytic therapy in early acute myocardial infarction.Methods 120 patients with early acute myocardial infarction treated in our hospital from October 2018 to October 2019 were selected as experimental subjects,and randomly divided into experimental group and control group according to the experimental requirements,with 60 patients in each group.Conventional treatment was used in the control group,while intravenous thrombolysis was used in the experimental group.The data of the two groups were recorded to compare the recanalization of blood vessels treated within 6h of onset and within 6-12h of treatment,and to compare the incidence of adverse reactions and the total effective rate of treatment in the two groups.Results The vascular recanalization rate of intravenous thrombolysis within 6h after onset was 86.67%in the experimental group,and 75.00%in the experimental group between 6 and 12h after onset(P<0.05).The incidence of adverse reactions in the experimental group was 15%lower than that in the control group(P<0.05).The total effective rate was 86.67%in the experimental group,higher than 63.33%in the control group(P<0.05).Conclusion Intravenous thrombolytic therapy for patients with early acute myocardial infarction can effectively improve the vascular recanalization rate and the total effective rate of treatment,reduce the incidence of adverse reactions,compared with the conventional treatment has a significant clinical effect,therefore,it is worthy of clinical promotion and application.

关 键 词：静脉溶栓 早期急性心肌梗死 临床效果 

分 类 号：R542.2+2[医药卫生—心血管疾病]